Should patient groups accept money from drug companies? No

AUTOR(ES)

Mintzes, Barbara

FONTE

BMJ Publishing Group Ltd.

RESUMO

Patient groups provide valuable support and advocacy for vulnerable people but funding the work can be difficult. Alastair Kent argues that not accepting industry money will unnecessarily limit the groups' effectiveness, but Barbara Mintzes believes that the money undermines their independence

Documentos Relacionados

• Should patient groups accept money from drug companies? Yes
• Should we loosen the grip on drug companies?
• A bad week for drug companies?
• Should drug companies be allowed to sponsor Cochrane reviews?
• Drug company influence extends to nurses, pharmacists, and patient groups